We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
Oxford Brain Diagnostics awarded FDA Breakthrough Device Designation for technology to predict Alzheimer’s Disease
The breakthrough diagnostics platform will offer clinicians a new path to evaluating the potential advancement of Alzheimer's Disease.
Oxford spinout Spybiotech partners Serum Institute of India on new potential vaccine for COVID-19.
Careershe aims to provide smartphone-based career advice to Chinese students
New Oxford spinout Oxsed will lead commercialisation of rapid, cost-effective COVID-19 test.
Collaboration with the Nuffield Department of Medicine, University of Oxford will use recombinant overlapping peptide technology to develop a novel vaccine and diagnostic tests for Covid-19
Welcome to the Oxford University Innovation Q1 2020 update. OUI is now a month into its status as a virtual company with the entire office working from home, but we remain very much open for business. Below you’ll find all the usual updates from OUI and news from our spinouts, as well as an update on how Oxford is responding to the ongoing crisis.
Developing a pipeline of small molecule therapeutics for patients with immunological and genetic disorders.
Y Combinator startup Prolific announces $1.2M seed round with participation from Pioneer Fund and prominent Silicon Valley Angel investors.